Is targeted therapy possible for patients with gastric adenocarcinoma?

被引：1
|
作者：
Kaya, Dilsa Mizrak [1 ]
Harada, Kazuto [1 ]
Ajani, Jaffer A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,FC10-3022, Houston, TX 77030 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2016年 / 17卷 / 18期
关键词：
DOUBLE-BLIND; CANCER;
D O I：
10.1080/14656566.2016.1236917
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2371 / 2374
页数：4
相关论文
共 50 条
  • [41] A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer
    Skorzewska, Magdalena
    Geca, Katarzyna
    Polkowski, Wojciech P.
    CANCERS, 2023, 15 (22)
  • [42] Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
    Yoshinami, Yuri
    Shoji, Hirokazu
    FUTURE SCIENCE OA, 2023, 9 (02):
  • [43] Surface antigens/receptors for targeted cancer treatment: The GnRH receptor/binding site for targeted adenocarcinoma therapy
    Eaveri, R
    Ben-Yehudah, A
    Lorberboum-Galski, H
    CURRENT CANCER DRUG TARGETS, 2004, 4 (08) : 673 - 687
  • [44] Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
    Xu, Donghan
    Luo, Yehao
    Wang, Peng
    Li, Jiaxin
    Ma, Linrui
    Huang, Jie
    Zhang, Hao
    Yang, Xiaoman
    Li, Liqi
    Zheng, Yuhong
    Fang, Gang
    Yan, Peiyu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma
    Akazawa, Yoichi
    Ueyama, Hiroya
    Hayashi, Takuo
    Utsunomiya, Hisanori
    Uchida, Ryota
    Abe, Daiki
    Oki, Shotaro
    Suzuki, Nobuyuki
    Ikeda, Atsushi
    Yatagai, Noboru
    Komori, Hiroyuki
    Takeda, Tsutomu
    Matsumoto, Kohei
    Ueda, Kumiko
    Matsumoto, Kenshi
    Asaoka, Daisuke
    Hojo, Mariko
    Saito, Tsuyoshi
    Yao, Takashi
    Nagahara, Akihito
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 725 - 734
  • [46] Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma
    Shen, Chan
    Holguin, Rolfy A. Perez
    Schaefer, Eric
    Zhou, Shouhao
    Belani, Chandra P.
    Ma, Patrick C.
    Reed, Michael F.
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [47] Accuracy of endoscopic ultrasound in gastric adenocarcinoma patient selection for neoadjuvant therapy
    Costa, Juliana M.
    Goncalves, Bruno
    Gomes, Maria Miguel
    Fernandes, Dalia
    Goncalves, Raquel
    Soares, Joao B.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (02) : 278 - 286
  • [48] Esophagogastric Junction and Gastric Adenocarcinoma: Neoadjuvant and Adjuvant Therapy, and Future Directions
    Sandier, Steven
    ONCOLOGY-NEW YORK, 2014, 28 (06): : 505 - 512
  • [49] Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
    Huang, Long
    Jiang, Xiao-Liu
    Liang, Hong-Bin
    Li, Jian-Cheng
    Chin, Li-Han
    Wei, Jian-Ping
    Wang, Rui-Ru
    Cai, Jing
    Xiong, Qiang
    Wang, Lien-Tu
    Cram, David S.
    Liu, An-Wen
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [50] Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
    Kim, Seok-Young
    Lee, Ji Yeon
    Kim, Dong Hwi
    Joo, Hyeong Seok
    Yun, Mi Ran
    Jung, Dongmin
    Yun, Jiyeon
    Heo, Seong Gu
    Ahn, Beung-Chul
    Park, Chae Won
    Pyo, Kyoung Ho
    Chun, You Jin
    Hong, Min Hee
    Kim, Hye Ryun
    Cho, Byoung Chul
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345